BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6214231)

  • 1. [Coronary flow in experimental cardiac hypertrophy caused by arterial hypertension].
    Wicker P; Tarazi R; Dallocchio M; Bricaud H
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():133-6. PubMed ID: 6214231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of perindopril on left ventricular hypertrophy, coronary reserve and mechanical properties of the papillary muscle of the rat with renovascular arterial hypertension].
    Gosse P; Grellet J; Bonoron S; Tariosse L; Besse P; Dallocchio M
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):905-10. PubMed ID: 2959235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of exercise on coronary circulation in left ventricular hypertrophy caused by hypertension].
    Wicker P; Tarazi RC
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):813-6. PubMed ID: 2948470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of nicardipine on left ventricular hypertrophy of the rat with renovascular arterial hypertension].
    Grellet J; Bonoron-Adèle S; Stuyvers B; Tariosse L; Besse P
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():45-9. PubMed ID: 2973301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary blood flow during the development and regression of left ventricular hypertrophy in renovascular hypertensive rats.
    Wicker P; Tarazi RC; Kobayashi K
    Am J Cardiol; 1983 Jun; 51(10):1744-9. PubMed ID: 6222644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
    Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
    Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects.
    Palmieri V; Storto G; Arezzi E; Pellegrino T; Mancini M; Di Minno G; Ferrara AL; Cuocolo A; Celentano A
    J Hum Hypertens; 2005 Dec; 19(12):941-50. PubMed ID: 16079883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary flow velocity reserve is diminished in hypertensive left ventricular hypertrophy.
    Nemes A; Neu K; Forster T; Kovacs Z; Csanady M
    Kardiol Pol; 2005 Jan; 62(1):1-5. PubMed ID: 15815773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coronary circulation in cardiac hypertrophy.
    Sheridan DJ; McAinsh A; O'Gorman DJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S18-28. PubMed ID: 7508057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional myocardial blood flow in left ventricular hypertrophy. An experimental investigation in Newfoundland dogs with congenital subaortic stenosis.
    Borkon AM; Jones M; Bell JH; Pierce JE
    J Thorac Cardiovasc Surg; 1982 Dec; 84(6):876-85. PubMed ID: 6216374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of reversal of hypertensive cardiac hypertrophy by captopril on left ventricular pumping ability and performance.
    Saragoça MA; Cezaretti ML; Bessa AM; Casarini D; Almeida JB; Amorim MP; Ramos OL
    J Hypertens Suppl; 1987 Dec; 5(5):S403-6. PubMed ID: 2965226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular pressure overload during postnatal development. Effects on coronary vasodilator reserve and tolerance to hypothermic global ischemia.
    Yamamoto H; Avkiran M
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):120-31. PubMed ID: 8419692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular coronary flow in arterial hypertension.
    Wicker P; Tarazi RC
    Am Heart J; 1985 Oct; 110(4):845-50. PubMed ID: 2931969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to the identification of pathogenetic factors and to therapy in human primary hypertension.
    Korner PI; Jennings GL; Esler MD; Broughton A
    J Clin Hypertens; 1987 Jun; 3(2):187-96. PubMed ID: 2956375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The flow-pressure relationship in coronary perfusion in myocardial hypertrophy in hypertension].
    De Cesare N; Apostolo A; Fabbiocchi F; Loaldi A; Montorsi P; Polese A; Guazzi MD
    Cardiologia; 1990 Jul; 35(7):561-8. PubMed ID: 2150927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I.
    Donohue TJ; Dworkin LD; Ma J; Lango MN; Catanese VM
    J Investig Med; 1997 Dec; 45(9):584-91. PubMed ID: 9444886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension.
    Galderisi M; de Simone G; D'Errico A; Sidiropulos M; Viceconti R; Chinali M; Mondillo S; de Divitiis O
    Am J Hypertens; 2008 Sep; 21(9):1040-6. PubMed ID: 18600214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of cardiac hypertrophy by medical treatment.
    Tarazi RC; Fouad FM
    Annu Rev Med; 1985; 36():407-14. PubMed ID: 3158269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.